WFSBP 2019 Final Program

WFSBP 2019 67 Industry Sponsored Satellite Symposia aa Monday, 3 June 2019 LS-01 INDUSTRY SPONSORED SAT. SYMPOSIUM 13:15–14:45 Ballroom A Optimizing treatment strategies for patients with major depressive disorder (MDD) who do not respond adequately to antidepressants (Otsuka Pharmaceutical Development & Commercialization Inc. and H. Lundbeck A/S) Chair: Diane McIntosh, Canada 001 Developing drugs with different mechanisms of action to optimise therapy in MDD Leslie Citrome, USA 002 What should be the goal for treatment of MDD, and how do we get there? Zahinoor Ismail, Canada 003 Inadequate responses to antidepressant treatments in major depressive disorder (MDD): the patient’s per- spective Diane McIntosh, Canada 004 Emerging clinical data in the treatment of MDD Gustavo Alva, USA LS-02 INDUSTRY SPONSORED SAT. SYMPOSIUM 13:15–14:45 East Meeting Room 8/15 Pediatric and adult Bipolar Depression: Diagnostic challenges, disease burden, and treatment options (Sumitomo Dainippon Pharma) Chair: Roger McIntyre, Canada 001 Introduction Roger McIntyre , Canada 002 Pediatric Bipolar Depression Manpreet Singh, USA 003 Bipolar Depression in adults Roger McIntyre, Canada 004 Case challenges 005 Q&A aa Tuesday, 4 June 2019 LS-03 INDUSTRY SPONSORED SAT. SYMPOSIUM 13:15–14:45 Ballroom A Advances in psychiatry: Targeting glutamate in major depressive episodes (Janssen) Chair: Siegfried Kasper, Austria 001 Introduction Siefried Kasper, Austria 002 Overview of the glutamate system in the brain Pierre Blier, Canada 003 Canadian MDD landscape, clinical results in treat- ment-resistant major depressive episodes Raymond Lam, Canada 004 Clinical effectiveness of new emerging therapies in MDD Gerard Sanacora, USA aa Wednesday, 5 June 2019 LS-04 INDUSTRY SPONSORED SAT. SYMPOSIUM 13:15–14:45 Ballroom A The management of mania in bipolar I disorder: implications for long-term functioning (Otsuka Pharmaceutical Development & Commercialization Inc. and H. Lundbeck A/S) Chair: Lakshmi Yatham, Canada 001 Acute mania and Bipolar Disorder, diagnosis and treatment Gary Sachs, USA 002 Impact of early intervention in the course of bipolar I disorder Lakshmi Yatham, Canada 003 Functioning in patients with Bipolar I Disorder Iria Grande, Spain LS-05 INDUSTRY SPONSORED SAT. SYMPOSIUM 13:15–14:45 East Meeting Room 8/15 Targeting recovery in Schizophrenia: The role of early intervention, digital health, and multiple symptom domains (Sumitomo Dainippon Pharma) Chair: John M. Kane, USA 001 Introduction: New directions in the treatment of early phase schizophrenia: The importance of resilience, recovery and the use of technology John M. Kane, USA 002 New multimodal therapeutic approach to realize recovery in patients with schizophrenia Kazuyuki Nakagome, Japan 003 Q&A 004 Going beyond positive symptoms to improve out- comes in schizophrenia Christoph U. Correll, USA/Germany 005 Q&A